Literature DB >> 23939944

Generation of functional, antigen-specific CD8+ human T cells from cord blood stem cells using exogenous Notch and tetramer-TCR signaling.

Irina Fernandez1, Tracy P Ooi, Krishnendu Roy.   

Abstract

In vitro differentiation of mouse and human stem cells into early T cells has been successfully demonstrated using artificial Notch signaling systems. However, generation of mature, antigen-specific, functional T cells, directly from human stem cells has remained elusive, except when using stromal coculture of stem cells retrovirally transfected with antigen-specific T cell receptors (TCRs). Here we show that human umbilical cord blood (UCB)-derived CD34+CD38-/low hematopoietic stem cells can be successfully differentiated into functional, antigen-specific cytotoxic CD8+ T cells without direct stromal coculture or retroviral TCR transfection. Surface-immobilized Notch ligands (DLL1) and stromal cell conditioned medium successfully induced the development of CD1a+CD7+ and CD4+CD8+ early T cells. These cells, upon continued culture with cytomegalovirus (CMV) or influenza-A virus M1 (GIL) epitope-loaded human leukocyte antigen (HLA)-A*0201 tetramers, resulted in the generation of a polyclonal population of CMV-specific or GIL-specific CD8+ T cells, respectively. Upon further activation with antigen-loaded target cells, these antigen-specific, stem cell-derived T cells exhibited cytolytic functionality, specifically CD107a surface mobilization, interferon gamma (IFNg) production, and Granzyme B secretion. Such scalable, in vitro generation of functional, antigen-specific T cells from human stem cells could eventually provide a readily available cell source for adoptive transfer immunotherapies and also allow better understanding of human T cell development.
Copyright © 2013 AlphaMed Press.

Entities:  

Keywords:  Adult hematopoietic stem cells; CD34+ cells; Cytotoxic T cells; Human cord blood

Mesh:

Substances:

Year:  2014        PMID: 23939944      PMCID: PMC4193361          DOI: 10.1002/stem.1512

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  50 in total

Review 1.  T-cell development and the CD4-CD8 lineage decision.

Authors:  Ronald N Germain
Journal:  Nat Rev Immunol       Date:  2002-05       Impact factor: 53.106

2.  Enhanced T-cell reconstitution by hematopoietic progenitors expanded ex vivo using the Notch ligand Delta1.

Authors:  Mari H Dallas; Barbara Varnum-Finney; Paul J Martin; Irwin D Bernstein
Journal:  Blood       Date:  2007-01-09       Impact factor: 22.113

3.  Cutting Edge: Rag deletion in peripheral T cells blocks TCR revision.

Authors:  J Scott Hale; Kristina T Ames; Tamar E Boursalian; Pamela J Fink
Journal:  J Immunol       Date:  2010-04-30       Impact factor: 5.422

Review 4.  Ex vivo expansion of hematopoietic precursors, progenitors, and stem cells: the next generation of cellular therapeutics.

Authors:  S G Emerson
Journal:  Blood       Date:  1996-04-15       Impact factor: 22.113

5.  Evaluation of the CD107 cytotoxicity assay for the detection of cytolytic CD8+ cells recognizing HER2/neu vaccine peptides.

Authors:  Elizabeth A Mittendorf; Catherine E Storrer; Craig D Shriver; Sathibalan Ponniah; George E Peoples
Journal:  Breast Cancer Res Treat       Date:  2005-07       Impact factor: 4.872

6.  T-cell adoptive immunotherapy of metastatic renal cell carcinoma.

Authors:  G E Plautz; R M Bukowski; A C Novick; E A Klein; E D Kursh; T E Olencki; R J Yetman; A Pienkny; K Sandstrom; S Shu
Journal:  Urology       Date:  1999-10       Impact factor: 2.649

Review 7.  Memory T cells need CD28 costimulation to remember.

Authors:  Alina C Boesteanu; Peter D Katsikis
Journal:  Semin Immunol       Date:  2009-03-05       Impact factor: 11.130

8.  Cost effectiveness of cord blood versus bone marrow and peripheral blood stem cells.

Authors:  Thomas Bart
Journal:  Clinicoecon Outcomes Res       Date:  2010-10-05

9.  Density of the Notch ligand Delta1 determines generation of B and T cell precursors from hematopoietic stem cells.

Authors:  Mari H Dallas; Barbara Varnum-Finney; Colleen Delaney; Keizo Kato; Irwin D Bernstein
Journal:  J Exp Med       Date:  2005-04-25       Impact factor: 14.307

10.  Interleukin 7 receptor control of T cell receptor gamma gene rearrangement: role of receptor-associated chains and locus accessibility.

Authors:  S K Durum; S Candèias; H Nakajima; W J Leonard; A M Baird; L J Berg; K Muegge
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

View more
  9 in total

Review 1.  Applications of molecular engineering in T-cell-based immunotherapies.

Authors:  David A McBride; Matthew D Kerr; Shinya L Wai; Nisarg J Shah
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2019-04-10

Review 2.  Engineering cord blood to improve engraftment after cord blood transplant.

Authors:  Rohtesh S Mehta; Hema Dave; Catherine M Bollard; Elizabeth J Shpall
Journal:  Stem Cell Investig       Date:  2017-05-25

Review 3.  T Cell Genesis: In Vitro Veritas Est?

Authors:  Patrick M Brauer; Jastaranpreet Singh; Sintia Xhiku; Juan Carlos Zúñiga-Pflücker
Journal:  Trends Immunol       Date:  2016-10-24       Impact factor: 16.687

4.  Progenitor T-cell differentiation from hematopoietic stem cells using Delta-like-4 and VCAM-1.

Authors:  Shreya Shukla; Matthew A Langley; Jastaranpreet Singh; John M Edgar; Mahmood Mohtashami; Juan Carlos Zúñiga-Pflücker; Peter W Zandstra
Journal:  Nat Methods       Date:  2017-04-10       Impact factor: 28.547

Review 5.  In Vitro T-Cell Generation From Adult, Embryonic, and Induced Pluripotent Stem Cells: Many Roads to One Destination.

Authors:  Michelle J Smith; Beau R Webber; Mahmood Mohtashami; Heather E Stefanski; Juan Carlos Zúñiga-Pflücker; Bruce R Blazar
Journal:  Stem Cells       Date:  2015-08-11       Impact factor: 6.277

Review 6.  Biomaterial Strategies for Immunomodulation.

Authors:  Nathan A Hotaling; Li Tang; Darrell J Irvine; Julia E Babensee
Journal:  Annu Rev Biomed Eng       Date:  2015-09-29       Impact factor: 9.590

Review 7.  Engineering approaches for regeneration of T lymphopoiesis.

Authors:  Kyung-Ho Roh; Krishnendu Roy
Journal:  Biomater Res       Date:  2016-06-29

8.  Enhanced cytotoxic T lymphocytes recruitment targeting tumor vasculatures by endoglin aptamer and IP-10 plasmid presenting liposome-based nanocarriers.

Authors:  Xiaomei Yang; Jing Zhao; Siliang Duan; Xiaoqiong Hou; Xi Li; Zixi Hu; Zhuoran Tang; Fengzhen Mo; Xiaoling Lu
Journal:  Theranostics       Date:  2019-05-31       Impact factor: 11.556

9.  Umbilical cord blood-derived CD11c(+) dendritic cells could serve as an alternative allogeneic source of dendritic cells for cancer immunotherapy.

Authors:  Jeetendra Kumar; Vaijayanti Kale; Lalita Limaye
Journal:  Stem Cell Res Ther       Date:  2015-09-25       Impact factor: 6.832

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.